IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Mr. Patrick Mercer is the President of IRIDEX Corp, joining the firm since 2018.
What is the price performance of IRIX stock?
The current price of IRIX is $1.04, it has increased 1.92% in the last trading day.
What are the primary business themes or industries for IRIDEX Corp?
IRIDEX Corp belongs to Health Care industry and the sector is Health Care
What is IRIDEX Corp market cap?
IRIDEX Corp's current market cap is $18.1M
Is IRIDEX Corp a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for IRIDEX Corp, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell